Related Experiment Video
Updated: Mar 23, 2026

Author Spotlight: Elucidating the Pathways of TFH Cell Differentiation in Acute LCMV Challenges
Published on: April 26, 2024
Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection
C Agrati1,2, C Castilletti1, R Casetti2
1Virology Laboratory, INMI-IRCCS "L.Spallanzani", Rome, Italy.
Insights
Ebola virus disease (EVD) causes early CD4 T-cell decline and dysfunctional T-cell activation, marked by exhaustion and impaired function. This immune subversion may contribute to EVD pathogenesis and potential late neurological complications.
Area of Science:
- Immunology
- Virology
- Infectious Diseases
Background:
- Limited data exists on immune responses during human Ebola virus disease (EVD) due to safety and logistical constraints.
- Previous studies noted sustained T-cell activation, but functional analyses during acute EVD were lacking.
Purpose of the Study:
- To investigate the kinetics and function of T-cell subsets during acute EVD.
- To assess markers of T-cell activation, autophagy, apoptosis, and exhaustion until patient recovery.
Main Methods:
- Sequential sampling and analysis of two EVD patients from symptom onset to recovery.
- Utilized flow cytometry and ELISpot assay to evaluate T-cell subsets and functional markers.
Main Results:
- Observed early, sustained CD4 T-cell decrease and inverted CD4/CD8 ratio, normalizing during recovery.
- Detected massive T-cell activation with autophagic/apoptotic phenotype, increased PD-1 expression, and reduced IFN-gamma production.
- Noted EBV reactivation alongside immunological impairment.
Conclusions:
- Early, sustained, dysfunctional T-cell activation and CD4 T-cell decline represent a critical immune subversion mechanism in EVD.
- Monitoring immune recovery is crucial for assessing risks of late sequelae, including EVD-associated neurological disease.
- Further research is needed to elucidate the molecular mechanisms of EVD-driven T-cell dysfunction.
Abstract:
Data on immune responses during human Ebola virus disease (EVD) are scanty, due to limitations imposed by biosafety requirements and logistics. A sustained activation of T-cells was recently described but functional studies during the acute phase of human EVD are still missing. Aim of this work was to evaluate the kinetics and functionality of T-cell subsets, as well as the expression of activation, autophagy, apoptosis and exhaustion markers during the acute phase of EVD until recovery. Two EVD patients admitted to the Italian National Institute for Infectious Diseases, Lazzaro Spallanzani, were sampled sequentially from soon after symptom onset until recovery and analyzed by flow cytometry and ELISpot assay. An early and sustained decrease of CD4 T-cells was seen in both patients, with an inversion of the CD4/CD8 ratio that was reverted during the recovery period. In parallel with the CD4 T-cell depletion, a massive T-cell activation occurred and was associated with autophagic/apoptotic phenotype, enhanced expression of the exhaustion marker PD-1 and impaired IFN-gamma production. The immunological impairment was accompanied by EBV reactivation. The association of an early and sustained dysfunctional T-cell activation in parallel to an overall CD4 T-cell decline may represent a previously unknown critical point of Ebola virus (EBOV)-induced immune subversion. The recent observation of late occurrence of EBOV-associated neurological disease highlights the importance to monitor the immuno-competence recovery at discharge as a tool to evaluate the risk of late sequelae associated with resumption of EBOV replication. Further studies are required to define the molecular mechanisms of EVD-driven activation/exhaustion and depletion of T-cells.
More Related Videos
10:11Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
07:17Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
Published on: June 22, 2016